Lumida
/SBC
⌘K
SBC Medical Group Holdings Inc

SBC Medical Group Holdings Inc

SBC
$4.11USD-0.72%-0.03 today

MARKET CAP

422.7M

P/E (TTM)

7.8x

FWD P/E

7.6x

DAY RANGE

$4 – $4

52W RANGE

$3
$5

AI Summary

Stalk
TrimMedium

SBC remains in a Stage 4 decline with persistent lower highs and lower lows and price trading below all major EMAs. The medium-term bias is bearish, as the active Post-Capitulation pattern signals only exhaustion without structural repair. Extreme oversold conditions counsel caution, so execution will focus on trimming into rallies toward the 9/20 EMA resistance zone.

  • Underlying revenue grew 111% YoY (ex-$8.7M fee impact) reflecting strong recovery
  • EBITDA +117% (ex-fee adjustments) underscoring improving margin trajectory
  • Total revenue -9% YoY to $43M after April fee structure changes
Full analysis →
Insider Trades3 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Apr 28, 2026SellSBCYoshiyuki AikawaChairman and CEO465,000$3.02$422.7M-18.93%+47.84%$1.4M-0.59%Stalk
Apr 21, 2026SellSBCYoshiyuki AikawaChairman and CEO3,100,000$3.02$422.7M-18.93%+47.84%$9.4M-3.76%Stalk
Mar 6, 2026SellSBCYoshiyuki AikawaChairman and CEO4,422,900$2.12$422.7M-18.93%+47.84%$9.4M-82.32%Stalk